Levetiracetam Zydus

Levetiracetam, the active ingredient in Levetiracetam Zydus, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam Zydus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. - Partial seizures: helps control focal onset seizures and reduces their frequency. - Generalized tonic‑clonic seizures: provides seizure freedom or reduction in patients with primary generalized seizures. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate cranial pain. - Irritability: mood changes including agitation. - Nausea: upset stomach or feeling sick. - Fatigue: reduced energy levels.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Mood disorders: depression, anxiety, or suicidal thoughts. - Allergic reactions: anaphylaxis, swelling of face or throat. - Blood dyscrasias: leukopenia, thrombocytopenia, or anemia. - Hepatic injury: elevated liver enzymes or hepatitis. - Respiratory depression: rare but potentially life‑threatening breathing difficulty.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for adverse events. - Renal impairment: assess kidney function and consider dose adjustment. - Hepatic dysfunction: monitor liver enzymes periodically. - Psychiatric history: watch for mood changes, depression, or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy and lactation: weigh potential benefits against unknown risks; discuss with obstetric specialist. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Levetiracetam has a relatively low interaction profile, but certain drugs can alter its plasma levels.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., carbamazepine, phenytoin, phenobarbital): may markedly reduce levetiracetam concentrations. - Concomitant use with other antiepileptics that lower seizure threshold: may increase risk of breakthrough seizures.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression and increase somnolence. - Sedative agents (e.g., benzodiazepines, opioids): may potentiate sedation and dizziness. - Antacids containing aluminum or magnesium: may slightly decrease absorption if taken simultaneously.